An exploratory analysis of COVID-19 vaccination administration

The goal of this research is to analyze data on vaccinations, vaccination administration, and forecasting vaccination rates on a country-by-country basis for the general public, policymakers, vaccine manufacturers, national governments, and international governments to better understand the current state of COVID-19 vaccination. In this study, two public datasets were used: the Johns Hopkins University coronavirus 2019 dataset and Our World in Data - Coronavirus Pandemic dataset. With datasets, two approaches have been used: visual data analysis for COVID-19 vaccine administration and the autoregressive integrated moving average (ARIMA) model for forecasting vaccination rates. The findings confirm that Oxford/AstraZeneca is the top vaccine used across the globe with 26.54%, the United States is the top in vaccination, with 277,290,173, India is the top in number of daily vaccinations with 3.659357M, and in total vaccinations per hundred people, the United States has the highest count with 82.91, among the top five countries. It is also estimated that the vaccination rate in the United States will reach almost 60%, while India, Brazil, France, and Turkey will reach about 15%, 28%, 60%, and 23%, respectively, in the following 50 days beginning 20 May 2021. This exploratory study of COVID-19 vaccination data was carried out to effectively show the current state of COVID-19 vaccine administration and to anticipate vaccination rates in the United States, India, Brazil, France, and Turkey.